Jmîchaeĺe Keller, President and CEO of Steep Hill has announced that it has licensed its cannabis testing technology to highly respected pain and addiction physician Dr. Carl Balog.
This is the first time a company has legally exported live cannabis genetics from North America to Europe.
Products containing either too little or too much CBD than labeled could negate potential clinical benefit to patients.
When cannabinoids activate signaling pathways in cancer cells they can stimulate a cell death mechanism called apoptosis, unleashing a potent anti-tumor effect.
The agency has issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes.
Planting cannabis for commercial production in remote locations is creating forest fragmentation, stream modification, soil erosion and landslides.
$5.5 million study to probe the impact of marijuana legalization on use, behavior, mental health.
In anticipation of California's new testing rules EVIO has invested in additional instrumentation to offer a full suite of testing services including pesticide, microbiological, and expanded cannabinoid potency testing.
The funding will be used to inform Canadians of the health and safety risks of cannabis use and drug-impaired driving.